SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001479290-22-000015
Filing Date
2022-02-04
Accepted
2022-02-04 20:35:34
Documents
2
Period of Report
2022-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164402491298660.html 4  
1 FORM 4 wf-form4_164402491298660.xml 4 4024
2 FOLEY POA 2022 ex-24.htm EX-24 3676
  Complete submission text file 0001479290-22-000015.txt   9108
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ZELTIQ AESTHETICS INC. 4698 WILLOW ROAD SUITE 100 PLEASANTON CA 94588
Business Address
Foley Mark J (Reporting) CIK: 0001529196 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 22595259